APA (7th ed.) Citation

Dehua Zhao, Xiaoqing Long, Jiping Zhou, & Jisheng Wang. (2023). Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Dehua Zhao, Xiaoqing Long, Jiping Zhou, and Jisheng Wang. Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System. Adis, Springer Healthcare, 2023.

MLA (9th ed.) Citation

Dehua Zhao, et al. Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System. Adis, Springer Healthcare, 2023.